Prothena Corporation News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.08.18	Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update (GlobeNewswire)
31.07.18	Prothena to Report Second Quarter 2018 Financial Results on August 7 (GlobeNewswire)
25.06.18	Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer (GlobeNewswire)
20.06.18	Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Prothena Corporation plc (PRTA) (PR Newswire)
19.06.18	Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology (GlobeNewswire)
05.06.18	Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury... (PR Newswire)
24.05.18	Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline (GlobeNewswire)
18.05.18	Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Prothena Corporation plc And Certain Of Its Current And Former Senior Executives (PR Newswire)
17.05.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Encourages Investors Who Suffered Losses Exceeding $2,000,000 Investing In Prothena Corporation plc (PRTA) To Contact The Firm (PR Newswire)
16.05.18	PROTHENA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Prothena Corporation plc To Contact The Firm (PR Newswire)
08.05.18	Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update (GlobeNewswire)
01.05.18	Prothena to Report First Quarter 2018 Financial Results on May 8 (GlobeNewswire)
24.04.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Prothena Corporation plc (PRTA) (PR Newswire)
24.04.18	Prothena Shareholder Alert - PRTA Stock Drops Almost 70% - Kehoe Law Firm, P.C. Investigating (PR Newswire)
24.04.18	PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA (RTTNews)
24.04.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prothena Corporation plc - PRTA (PR Newswire)
23.04.18	Prothena Decides To Discontinue Development Of NEOD001 For AL Amyloidosis (RTTNews)
23.04.18	Prothena Discontinues Development of NEOD001 for AL Amyloidosis (GlobeNewswire)
05.04.18	TENX Heartened After Meeting With FDA, RXII To Report Data In May, GALT On Watch (RTTNews)
22.03.18	GERN Turning Heads, ARQL To Present Data In Apr., Mark Your Calendar For PTN (RTTNews)
20.03.18	Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases (GlobeNewswire)
12.03.18	Prothena to Present a Broad Range of Scientific and Health Outcomes Data at the 16th International Symposium on Amyloidosis (GlobeNewswire)
07.03.18	Prothena to Participate in the Barclays Global Healthcare Conference (GlobeNewswire)
14.02.18	Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update (GlobeNewswire)
07.02.18	Prothena to Participate in the Leerink Partners 7th Annual Global Healthcare Conference (GlobeNewswire)
07.02.18	KALA Down 33% YTD, HAIR Recedes, Mark Your Calendar For Feb.23 (RTTNews)
06.02.18	Xtandi Prospers, One Down, One To Go For AMAG, There's Reason For CORT's Fall (RTTNews)
02.02.18	Prothena Announces Departure of Chief Medical Officer (GlobeNewswire)
01.02.18	Prothena to Report Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 14 (GlobeNewswire)
03.01.18	Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
22.11.17	Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference (GlobeNewswire)
21.11.17	SMMT To Report Data In Q1, PRTA Slumps, DBVT's Viaskin Value Realised (RTTNews)
16.11.17	Prothena Highlights Breadth of Novel Pipeline at R&D Day (GlobeNewswire)
07.11.17	Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update (GlobeNewswire)
01.11.17	Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference (GlobeNewswire)
31.10.17	Prothena to Report Third Quarter 2017 Financial Results on November 7 (GlobeNewswire)
28.09.17	Prothena Reports Results from Phase 1b Multiple Ascending Dose Study of PRX003 in Patients with Psoriasis (GlobeNewswire)
18.09.17	Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis (GlobeNewswire)
15.08.17	Prothena to Present New Research on Cardiac Biomarker NT-proBNP in AL Amyloidosis at HFSA Annual Meeting (GlobeNewswire)
08.08.17	Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update (GlobeNewswire)
01.08.17	Prothena to Report Second Quarter 2017 Financial Results on August 8 (GlobeNewswire)
06.07.17	ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG (RTTNews)
03.03.17	Learn how to target a 58% return on AveXis Inc., or get option-trade ideas on Ionis Pharmaceuticals, The Medicines Co, Prothena and Tesaro Inc. or any stock you choose (PR Newswire)
15.02.17	AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO (RTTNews)
15.12.16	Prothena Announces Appointment of Chief Regulatory Officer (GlobeNewswire)
10.11.16	ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise (RTTNews)
09.11.16	Prothena Reports Results from Phase 1b Study of PRX002 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson's Disease (GlobeNewswire)
03.11.16	Data for Prothena's NEOD001 to be Presented at the 58th Annual American Society of Hematology Meeting (GlobeNewswire)
02.11.16	PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Prothena Corporation PLC

Aktien Top/Flop

Meistgelesene Nachrichten